Skip to main content
👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources. Claim this profile →
Dr Daniel Smith
Trust score 8/100 Accepting new patients

Dr

Dr Daniel Smith

Oncology

English
10,622+ Patients seen
2 Years in practice
10 Publications
1 Languages spoken

About

Dr Daniel Smith is a Consultant Clinical Oncologist at Guy's and St Thomas' NHS Foundation Trust. He specialises in the treatment of thoracic and breast cancers including: Lung Cancer, Breast Cancer, Mesothelioma, Thymic tumours, Chemotherapy, Radiotherapy. He also delivers immediate post-operative radiotherapy for benign conditions including: Heterotopic Ossification (HO) and Pigmented Villonodular Synovitis (PVNS). He has a particular focus on high precision techniques including 3D and 4D conformal image-guided radiotherapy (IGRT), intensity modulation radiotherapy (IMRT), volumetric modulated arc therapy (VMAT) and stereotactic ablative radiotherapy (SABR).

Dr Smith is the Lead Clinician for Lung Cancer at Guy's & St Thomas', one of the largest lung cancer services in the country. He is the Clinical Governance Lead for the Oncology Directorate, has published papers in international journals on IMRT and the incorporation of nuclear medicine into practice, and is an investigator in several active clinical trials. He gained a First Class degree at the University of Cambridge and completed medical training at University College London Medical School. He became a member of the Royal College of Physicians in 2004 and a fellow of the Royal College of Radiologists in 2008 following higher clinical oncology training in North London.

Diseases, Medical Tests and Treatments
• Immunotherapy

• Chemotherapy

• 3D and 4D conformal image-guided radiotherapy (IGRT)

• Intensity Modulated Radiotherapy (IMRT)

• Volumetric modulated arc therapy (VMAT)

• Stereotactic Radiotherapy (SABR)

• Heterotopic Ossification (HO)

• Pigmented Villonodular Synovitis (PVNS)

• Lung Cancer

• Breast cancer

• Mesothelioma

• Thymic tumours

“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”

— Dr Daniel Smith

Education & training

  1. 2014–2020 MD · Medicine and Surgery
    Universidad de Navarra
  2. 2020–2024 Residency · Oncology
    Universidad de Navarra

Career & appointments

  1. 2024-09–2025-08 Junior consultant
    Universidad de Navarra Teaching Hospital — Oncology

Licenses & insurance

Medical licenses

— Organización Médica Colegial de España (OMC)
#-509697 active · expires 2028-12-31

Board certifications

European Board of Oncology
#EB-0AE07215 · issued 2025 · renewal 2035
Malpractice insurance: HDI Global · 5,000,000 EUR coverage · No claims on file

Procedures performed

ProcedureCodeLifetime count
GP consultation 99213 2,884
Annual physical exam 99395 2,370
Vaccination administration 90471 602
Minor procedure (skin) 17110 1,885

Services & pricing

ServiceDurationModalityPrice
New patient consultation (60m) 60 min in_clinic|telemed 180.00 EUR
Follow-up consultation (30m) 30 min in_clinic|telemed|phone 90.00 EUR
Vaccination administration 90 min in_clinic 360.00 EUR
Minor procedure (skin) 60 min in_clinic 270.00 EUR

Office, team & in practice

Daniel Smith
HEADSHOT
Daniel Smith in consultation
IN OFFICE
Daniel Smith with the team
WITH TEAM
Daniel Smith at a conference
CONFERENCE

Videos

introduction · 133s
Meet Daniel Smith

Research & publications

h-index: 5 · i10: 7

  1. Long-term follow-up of Oncology across
    Daniel Smith, et al. · European Journal of Medicine, 2026
    DOI: 10.8511/euroclin.2026.0 · PMID: 39470215 · cited by 132
  2. Validation of clinical scoring in Oncology
    Daniel Smith, et al. · European Journal of Medicine, 2025
    DOI: 10.5491/euroclin.2025.1 · PMID: 34040864 · cited by 14
  3. Long-term follow-up of Oncology across
    Daniel Smith, et al. · European Journal of Medicine, 2024
    DOI: 10.5295/euroclin.2024.2 · PMID: 36974862 · cited by 200
  4. Validation of clinical scoring in Oncology
    Daniel Smith, et al. · European Journal of Medicine, 2023
    DOI: 10.8373/euroclin.2023.3 · PMID: 32117793 · cited by 82

Invited talks

  • Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
  • Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract

Awards & memberships

Awards

  • 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional

Society memberships

  • WONCA Europe — Family Doctors — Member · since 2025
  • national college of family doctors — Member · since 2025
  • European Union of Medical Specialists (UEMS) — Member · since 2025

Patient reviews

★ 0.00 5,213 verified reviews
Bedside Manner
0.05
Knowledge
0.08
Wait Time
3.80
Staff Friendliness
0.02
Ease Of Appointment
4.00
Value For Money
4.10
Would Recommend Pct
4
  • ★ 5 verified visit

    “Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”

    — Anna B. · 2026-05-11

  • ★ 5 verified visit

    “Took time to listen and reviewed all my previous results. I would absolutely recommend.”

    — Marco V. · 2026-04-14

  • ★ 4 verified visit

    “Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”

    — Helena F. · 2026-04-17

Articles by this doctor

  • Patient education Patient guide to Oncology
  • Awareness When should you see a oncology?

For international patients

Coordinator
Patient liaison · dr.daniel.smith@euroclinics.example

Similar specialists

Browse all →